Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In VFC To Contact Him Directly To Discuss Their Options
If you suffered losses in VFC between October 30, 2023 and May 20, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against V.F. Corporation (“VFC” or the “Company”) (NYSE: VFC) and reminds investors of the November 12, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: the true state of VFC’s turnaround plans; notably, that additional significant reset actions would be necessary to return the Vans brand to growth, resulting in significant setbacks to Vans’ revenue growth trajectory. These statements caused Plaintiff and other shareholders to purchase and/or acquire VFC’s securities at artificially inflated prices.
The truth emerged on May 21, 2025, when VFC reported its fourth quarter and full-year fiscal 2025 results, highlighting a significant decline in Vans’ growth trajectory, which faltered from an 8% loss the quarter before to a 20% loss in the fourth quarter, and noting such decline would continue through the next quarter. The Company attributed its results and below-expectation guidance largely as “a direct effect of deliberately reduced revenue to eliminate unprofitable or unproductive businesses” and “an additional set of deliberate actions” already in-place but previously unannounced. VFC further noted that, disregarding these deliberate actions, Vans would still have shown a “high single digit[]” revenue decline, suggesting growth slowed in comparison to the prior years’ sequential improvements irrespective of management’s new “deliberate actions.”
Investors and analysts reacted immediately to VFC’s revelation. The price of VFC’s common stock declined dramatically. From a closing market price of $14.43 per share on May 20, 2025, VFC’s stock price fell to $12.15 per share on May 21, 2025, a decline of about 15.8% in the span of just a single day.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding VFC’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the V.F. Corporation class action, go to www.faruqilaw.com/VFC or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d516bf4b-fab7-416f-a74a-ea4437d5b4b3
Analyst’s Disclosure:I/we have a beneficial long position in the shares of JEPQ, QYLD, NVDA, GOOG, AMZN, TSLA, META, AAPL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-12 13:135mo ago
2025-10-12 08:325mo ago
3 Driverless Car Stocks to Buy and Hold for at Least a Decade
It's not easy to find a way to invest in the future of driverless vehicles, but here are three companies that could become monsters over the long term.
"Autonomous vehicles have arrived for both rideshare and trucking," Goldman Sachs Research analyst Mark Delaney wrote this summer. "We believe the key focus for investors is now on the pace at which AVs [autonomous vehicles] will grow and how big the market will become, rather than if the technology works."
That's an exciting statement. Goldman Sachs' research also estimates that robotaxis' rideshare market will post a compound annual growth rate of roughly 90% from 2025 to 2030, at which point autonomous vehicles will generate about $7 billion in annual revenue with only 8% of the U.S. rideshare market. There's a lot of growth to be had as autonomous vehicles, robotaxis, and driverless trucks hit the roads.
Many investors are intrigued by the potential of driverless car stocks, but many aren't quite sure where to look yet. Here are three potentially monster driverless car stocks to consider.
It's all about the chip
Analog Devices (ADI -5.28%) is one of the world's largest makers of analog and mixed-signal chips, with a notably strong presence in analog signal processing chips. In the years ahead, the company is well positioned to thrive as more advanced and higher-priced semiconductor content fills automobiles, communications equipment, medical devices, and factory automation equipment.
Image source: Getty Images.
An especially intriguing and promising end market for Analog Devices is the automotive sector, where semiconductors are required to enable sensors, active safety systems, and advanced infotainment systems. But that's just the status quo. Electric vehicles (EVs) have even more semiconductor chip content per car, and driverless electric vehicles even more than that. Also, just for bonus points, ADI is positioned with a market share lead in battery management systems for electric vehicles.
EVs will drive lithium demand
Albemarle (ALB -6.88%) is one of the world's largest lithium producers, which easily generates the majority of its total profits. It produces lithium from its own salt brine assets in Chile, the United States, and two joint venture interests in Australian mines. Fun fact: Its Chilean operation is among the world's lowest-cost sources of lithium, putting its product and pricing in demand. Albemarle also owns resources in the U.S. and Argentina that are still in the early development phase, which will enable the company to boost its lithium volumes down the road.
It isn't at all far-fetched to think that as EV adoption increases, and eventually goes mainstream,, the company could post double-digit annual growth in global lithium demand over the next decade and perhaps longer.
And now might be a good time to look to the future and start a small position in this stock. That's because a lithium mine of rival Contemporary Amperex Technology Co., Limited (CATL) was temporarily shut down due to expired permits. That shutdown was expected to last six to 12 months, though ended up being only one month, meaning the lithium market will remain oversupplied for the near term, but prices could rise by mid-to-late 2026.
Better yet, according to Morningstar estimates, long-term lithium prices should average around $20,000 per metric ton, compared to current prices of roughly $9,500 per metric ton.
The holy grail of batteries
Over the past six months, QuantumScape (QS -1.93%) gave investors a taste of what future share gains could look like, soaring 310% over that time frame. QuantumScape is in the extreme early stages of its story and is attempting to produce solid-state lithium-metal batteries at commercial volume, which has yet to be done.
These solid-state batteries would excel in five critical metrics: energy density, charging speed, lifespan, safety, and cost-effectiveness. Basically, QuantumScape is hard at work ramping up testing and accelerating the production process of batteries that would propel the EV industry forward significantly.
QuantumScape also gave investors a taste of reality recently. On paper, these batteries may become be holy grail for the EV industry, but many investors remain in an "I'll believe it when I see it" mindset. While that's fair, QuantumScape did let its technology jump off the paper and demonstrated a Ducati motorcycle equipped with QSE-5 battery cells, which were produced using QuantumScape's highly anticipated Cobra production process -- a process that's one step closer to commercial volume production levels.
Remember these names
Electric vehicles are slowly taking over global roads -- in some regions faster than others -- and driverless vehicles are also slowly gaining traction as companies work through the technology and policy makers sift through and determine regulations.
There will be massive bumps in the road, to be sure, and the road is a long one. But these three companies offer exposure to the future of driverless vehicles through Albemarle's lithium, which should continue to be in high demand as EVs take over the roads, and through Analog Devices' semiconductor chips, which will see huge demand from electric driverless vehicles. Meanwhile, QuantumScape could be a generational winner if the company executes commercial volume of solid-state batteries.
If you're interested in investing in the long-term future of the automotive industry, keep these three stocks on your watch list; they could end up being monsters.
Daniel Miller has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Goldman Sachs Group. The Motley Fool has a disclosure policy.
2025-10-12 13:135mo ago
2025-10-12 08:325mo ago
QMCO INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Quantum
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Quantum Corporation To Contact Him Directly To Discuss Their Options
If you suffered losses in Quantum Corporation between November 15, 2024 and August 18, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Quantum Corporation (“Quantum Corporation” or the “Company”) (NASDAQ: QMCO) and reminds investors of the November 3, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
According to the lawsuit, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Quantum Corporation improperly recognized revenue during the fiscal year ended March 31, 2025; (2) Quantum Corporation would therefore need to restate its previously filed financial statements for the fiscal third quarter ended December 31, 2024; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.
On June 30, 2025, Quantum disclosed that it would be unable to timely file its annual financial report for the fiscal year 2025 as it is “reviewing its accounting related to certain revenue contracts as well as the application of standalone selling price under applicable accounting standards.”
On this news, Quantum’s stock price fell $1.00, or 10.03%, to close at $8.97 per share on June 30, 2025, thereby injuring investors.
Then, on August 8, 2025, Quantum announced that its third quarter 2024 financial statements “should no longer be relied upon” due to “deficiencies in the Company’s internal control over financial reporting and the Company’s disclosure controls and procedures that constituted material weaknesses.” The Company further disclosed that the affected financial statements would be restated to show a new decrease of approximately $3.9 million in revenue.
On this news, Quantum’s stock price fell $0.14, or 1.79%, to close at $7.66 per share on August 11, 2025.
Then, on August 18, 2025, Quantum disclosed that its CEO would be resigning from the role after only five months in the position.
On this news, Quantum’s stock price fell $0.61, or 8.2%, to close at $6.83 per share on August 19, 2025, thereby injuring investors further.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Quantum Corporation’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Quantum Corporation class action, go to www.faruqilaw.com/QMCO or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d516bf4b-fab7-416f-a74a-ea4437d5b4b3
SummaryThe Wisdomtree U.S. Quality Growth Fund ETF selects 100 large cap stocks with a methodology blending growth and quality metrics.QGRW is heavily concentrated in technology and mega-cap stocks, with the top 10 holdings making up over 63% of assets.QGRW has outperformed the S&P 500 and major competitors since inception, but this comes with higher volatility.While QGRW offers strong growth exposure, its short track record, volatility and portfolio concentration present notable long-term risks.Quantitative Risk & Value members get exclusive access to our real-world portfolio. See all our investments here » jittawit.21/iStock via Getty Images
This article updates my review published in September 2024 in light of recent performance and current holdings.
QGRW strategy Wisdomtree U.S. Quality Growth Fund ETF (NYSEARCA:QGRW) was launched on 12/15/2022 and tracks the WisdomTree
Analyst’s Disclosure:I/we have a beneficial long position in the shares of AMZN, META either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
2025-10-12 13:135mo ago
2025-10-12 08:375mo ago
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EW
, /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corporation (NYSE: EW).
If you currently own shares of Edwards stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=29704 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected].
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
SOURCE THE ROSEN LAW FIRM, P. A.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
2025-10-12 13:135mo ago
2025-10-12 08:395mo ago
KBR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of KBR
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options
If you suffered losses in KBR between May 6, 2025 and June 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against KBR, Inc. (“KBR” or the “Company”) (NYSE: KBR) and reminds investors of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Despite the knowledge that the U.S. Department of Defense’s Transportation Command (TRANSCOM) had, for months, had material concerns with HomeSafe’s ability to fulfill the Global Household Goods Contract, defendants claimed that the partnership was without issue, and would ramp up in future quarters; and (2) as a result, defendants statements about KBR’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
On June 19, 2025, after the market closed, HomeSafe issued a press release entitled “HomeSafe Alliance announces TRANSCOM’s Notice to Terminate Global Household Goods Contract.” The next day, before market hours, KBR issued a press release entitled “KBR Announcement on HomeSafe Alliance Global Household Goods Contract.”
On this news, the price of KBR stock fell $3.85 per share, or 7.29%, to close at $48.93 on June 20, 2025. On June 23, 2025, the next trading day, KBR stock fell a further $1.30, or 2.65%, to close at $47.63 on June 23, 2025.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding KBR’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the KBR class action, go to www.faruqilaw.com/KBR or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d516bf4b-fab7-416f-a74a-ea4437d5b4b3
2025-10-12 13:135mo ago
2025-10-12 08:415mo ago
CHTR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Charter Communications
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Charter To Contact Him Directly To Discuss Their Options
If you suffered losses in Charter between July 26, 2024 and July 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Charter Communications, Inc. (“Charter” or the “Company”) (NASDAQ: CHTR) and reminds investors of the October 13, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) the impact of the ACP end was a material event the Company was unable to manage or promptly move beyond; (ii) the ACP end was actually having a sustaining impact on Internet customer declines and revenue; (iii) neither was the Company executing broader operations in a way that would compensate for, or overcome the impact, of the ACP ending; (iv) the Internet customer declines and broader failure of Charter’s execution strategy created much greater risks on business plans and earnings growth than reported; (v) accordingly, the Company had no reasonable basis to state the Company was successfully executing operations, managing causes of Internet customer declines, or provide overly optimistic statements about the long term trajectory of the Company and EBITDA growth; and (iv) as a result of the foregoing, Defendants materially misled with, and/or lacked a reasonable basis for, their positive statements about the Company’s business, operations, outlook during the Class Period.
On July 25, 2025, Charter released its second quarter 2025 financial results, reporting that total internet customers had declined by 117,000, compared to about 100,000 in the second quarter of 2024, when adjusted to remove the prior year's impact of the end of the Affordable Connectivity Program. The Company's total video customers also decreased by 80,000.
On this news, Charter's stock price fell $70.25 per share, or 18.5%, to close at $309.75 per share on July 25, 2025.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Charter’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Charter Communications class action, go to www.faruqilaw.com/CHTR or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d516bf4b-fab7-416f-a74a-ea4437d5b4b3
2025-10-12 13:135mo ago
2025-10-12 08:415mo ago
This Underrated AI Stock is Readying Up for a 6G Boom
Qualcomm (NASDAQ:QCOM) stands out as one of the lesser-appreciated semiconductor names as the AI revolution continues to play out, while other emerging tech trends also start to gain traction among growth and momentum-focused investors.
2025-10-12 13:135mo ago
2025-10-12 08:425mo ago
LFMD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In LifeMD To Contact Him Directly To Discuss Their Options
If you suffered losses in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) and reminds investors of the October 27, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Defendants materially overstated LifeMD’s competitive position; (2) Defendants were reckless in raising LifeMD’s 2025 guidance, considering that they had not properly accounted for rising customer acquisition costs in LifeMD’s RexMD segment, as well as for customer acquisition costs related to the sale of drugs designed to treat obesity, including Wegovy and Zepbound; and (3) as a result, Defendants’ statements about LifeMD’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
On August 5, 2025, after the market closed, LifeMD reported its financial results for the second quarter of 2025. In this announcement, LifeMD announced revised guidance. Among other metrics, LifeMD stated that it was expecting total revenue in the range of $250 to $255 million, compared with previous guidance of $268 to $275 million.
On this news, LifeMD's stock plummeted 44.8% on August 6, 2025.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding LifeMD’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the LifeMD class action, go to www.faruqilaw.com/LFMD or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d516bf4b-fab7-416f-a74a-ea4437d5b4b3
2025-10-12 13:135mo ago
2025-10-12 08:445mo ago
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 8, 2025.
SO WHAT: If you purchased aTyr Pharma common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the aTyr Pharma class action, go to https://rosenlegal.com/submit-form/?case_id=46109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 8, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning the efficacy of Efzofitimod, particularly, the drug’s capability to allow a patient to completely taper their steroid usage. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the aTyr Pharma class action, go to https://rosenlegal.com/submit-form/?case_id=46109 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
2025-10-12 13:135mo ago
2025-10-12 08:445mo ago
SVRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Savara To Contact Him Directly To Discuss Their Options
If you suffered losses in Savara between March 7, 2024 and May 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) and reminds investors of the November 7, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the MOLBREEVI BLA lacked sufficient information regarding MOLBREEVI’s chemistry, manufacturing, and/or controls; (2) accordingly, the FDA was unlikely to approve the MOLBREEVI BLA in its current form; (3) the foregoing made it unlikely that Savara would complete its submission of the MOLBREEVI BLA within the timeframe it had represented to investors; (iv) the delay in MOLBREEVI’s regulatory approval increased the likelihood that the Company would need to raise additional capital; and (v) as a result, Defendants’ public statements were materially false and misleading at all relevant times.
On May 27, 2025, Savara issued a press release "announc[ing] that the Company received [a refusal to file] letter from the FDA for the [Biologics License Application] of MOLBREEVI as a therapy to treat patients with autoimmune PAP."
On this news, Savara's stock price fell $0.90 per share, or 31.69%, to close at $1.94 per share on May 27, 2025.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Savara’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Savara class action, go to www.faruqilaw.com/SVRA or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d516bf4b-fab7-416f-a74a-ea4437d5b4b3
2025-10-12 13:135mo ago
2025-10-12 08:465mo ago
NX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Quanex Building Products
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Quanex To Contact Him Directly To Discuss Their Options
If you suffered losses in Quanex between December 12, 2024 and September 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Quanex Building Products Corporation (“Quanex” or the “Company”) (NYSE: NX) and reminds investors of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company’s procedures and policies regarding tooling and equipment maintenance in its Tyman Mexico facility were significantly “underinvested”; (2) as a result, the Company’s tooling and equipment conditions had significantly degraded to near “catastrophic” levels; (3) that, as a result of the foregoing, the Company was likely to incur significant costs, “pushing out the timing” of expected benefits from the Tyman integration; (4) that Quanex had previously identified the foregoing issues; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
On September 4, 2025, after the market closed, Quanex announced financial results for the third quarter of the 2025 fiscal year. Among other things, the Company disclosed “operational issues related to the legacy Tyman window and door hardware business in Mexico that are ongoing” which “impacted results more than expected during the third quarter of 2025.” Specifically, the Company reported a diluted EPS of ($6.04), compared to $0.77 in the prior year period and an adjusted EBIDTA of $70.30. The Company further disclosed that it was “adjusting for lower expected volumes and pushing out the timing of when [it] expect[s] to realize procurement savings” from the integration of the Tyman business.
Then, on September 5, 2025, the Company held an earnings call pursuant to the Company’s third quarter 2025 financial results. During the earnings call, Chief Executive Officer, George Wilson (“Wilson”) explained “operational challenges” in the Tyman facility in Mexico “negatively impacted EBITDA in the Hardware Solutions segment by almost $5 million in the third quarter alone.” Wilson further explained that the issue was previously “identified midyear” as it got “deeper into the integration” with Tyman, and described how the systems used to “anticipate and plan for tooling repairs” were significantly deficient, indicating it was near “nonexistent.” Wilson stated because Quanex was “underinvested” in “the tooling condition and the equipment condition” it “had to make some changes and fix some things before it was catastrophic.”
On this news, Quanex’s stock price fell $2.73, or 13.1%, to close at $18.18 per share on September 5, 2025, on unusually heavy trading volume. The stock price continued to decline on the subsequent trading day, falling $1.98 or 10.9%, to close at $16.20 per share on September 8, 2025, on unusually heavy trading volume.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Quanex’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Quanex Building Products class action, go to www.faruqilaw.com/NX or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d516bf4b-fab7-416f-a74a-ea4437d5b4b3
2025-10-12 13:135mo ago
2025-10-12 08:525mo ago
UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Unicycive To Contact Him Directly To Discuss Their Options
If you suffered losses in Unicycive between March 29, 2024 and June 27, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY) and reminds investors of the October 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) Unicycive's readiness and ability to satisfy the FDA's manufacturing compliance requirements was overstated; (ii) the OLC NDA's regulatory prospects were likewise overstated; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.
On June 10, 2025, Unicycive issued a press release "announcing an update on its [NDA] for [OLC] to treat hyperphosphatemia in patients with [CKD] on dialysis." Therein, the Company disclosed that the FDA "had identified deficiencies in cGMP [current good manufacturing practice] compliance at a third-party manufacturing vendor"-specifically, a third-party subcontractor of Unicycive's contract development and manufacturing organization ("CDMO")-"following an FDA inspection" and that, "given the identified deficiencies, any label discussions between the FDA and the Company are precluded."
On this news, Unicycive's stock price fell $3.68 per share, or 40.89%, to close at $5.32 per share on June 10, 2025.
Then, on June 30, 2025, Unicycive issued a press release announcing that the FDA had issued a Complete Response Letter for the OLC NDA, citing the previously identified cGMP deficiencies at the third-party subcontractor of its CDMO.
On this news, Unicycive's stock price fell $2.03 per share, or 29.85%, to close at $4.77 per share on June 30, 2025.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Unicycive’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Unicycive Therapeutics class action, go to www.faruqilaw.com/UNCY or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d516bf4b-fab7-416f-a74a-ea4437d5b4b3
2025-10-12 13:135mo ago
2025-10-12 09:005mo ago
MCHI: Are We Missing The Real Impact Of China's Rare Earth Export Controls?
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-12 13:135mo ago
2025-10-12 09:005mo ago
GLD: 'Golden Collar' (And Other Options) Strategies Look Great Here To Lock In Gains
SummaryGLD and gold in general have surged higher in recent weeks. But gold is cyclical.I prefer to express my gold position through options alone, or via an option collar. I provide timely insight on those here.The "golden collar" involves buying puts and selling covered calls on GLD to set profit and loss boundaries after the recent rally.This is as good a time as I've seen for investors to learn how to use options responsibly and with confidence, given these unique market conditions.Looking for more investing ideas like this one? Get them exclusively at Sungarden Investors Club. Learn More » adventtr/E+ via Getty Images
When it comes to investing in gold, including via funds like SPDR Gold Shares ETF (NYSEARCA:GLD)...I don't. OK, let me explain that.
Maybe you remember those great commercials for Dos Equis beer featuring a character
Analyst’s Disclosure:I/we have a beneficial long position in the shares of GLD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
I own puts and calls, considering a collar soon.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
2025-10-12 13:135mo ago
2025-10-12 09:005mo ago
Johnson & Johnson To Acquire Protagonist? It'd Be A Good Deal To Make
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
SummaryA new trade war threat from President Trump just reshuffled the entire stock market.I discuss what the big gift to dividend investors is.I also share how I am taking advantage of President Trump's gift.Looking for a portfolio of ideas like this one? Members of High Yield Investor get exclusive access to our subscriber-only portfolios. Learn More » LPETTET/iStock Unreleased via Getty Images
President Donald Trump just gave a much-needed boost to dividend investors. In this article, I will detail what that gift is and share how I am positioning my portfolio to take advantage of it.
Analyst’s Disclosure:I/we have a beneficial long position in the shares of OKE, GLD, EPD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
SummaryU.S. equity markets tumbled in a sudden jolt of volatility as investors - already flying blind on key data - reacted to a surprise, massive tariff announcement on Chinese imports.The White House announced a 100% added tariff on all Chinese imports beginning next month - up from 30% currently - as retaliation to new export controls on rare minerals.The CBOE Volatility Index surged to the highest levels since mid-May in a sudden onset of angst following several months of relatively tranquil market conditions.While markets may have ordinarily taken the tariff news in stride, it was a step too far for some investors already uneasy about the recent blackout of economic data.Posting its worst week in five months, the S&P 500 dipped 2.4%. Real estate equities also slumped as a favorable retreat in benchmark interest rates was offset by sharp declines from economically sensitive property sectors.iREIT®+HOYA Capital members get exclusive access to our real-world portfolio. See all our investments here » Getty Images
Real Estate Weekly Outlook U.S. equity markets tumbled this past week in a sudden jolt of volatility as investors - already flying blind on key data amid the lingering shutdown - reacted to a surprise, massive tariff announcement on Chinese imports, which threatened to
Analyst’s Disclosure:I/we have a beneficial long position in the shares of RIET, HOMZ, IRET, ALL HOLDINGS IN THE IREIT+HOYA PORTFOLIOS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Hoya Capital Research & Index Innovations ("Hoya Capital") is an affiliate of Hoya Capital Real Estate, a registered investment advisory firm based in Rowayton, Connecticut, that provides investment advisory services to ETFs, individuals, and institutions. Hoya Capital Research & Index Innovations provides non-advisory services including market commentary, research, and index administration focused on publicly traded securities in the real estate industry. This published commentary is for informational and educational purposes only. Nothing on this site nor any commentary published by Hoya Capital is intended to be investment, tax, or legal advice or an offer to buy or sell securities. This commentary is impersonal and should not be considered a recommendation that any particular security, portfolio of securities, or investment strategy is suitable for any specific individual, nor should it be viewed as a solicitation or offer for any advisory service offered by Hoya Capital Real Estate. Please consult with your investment, tax, or legal adviser regarding your individual circumstances before investing. The views and opinions in all published commentary are as of the date of publication and are subject to change without notice. Information presented is believed to be factual and up-to-date, but we do not guarantee its accuracy, and it should not be regarded as a complete analysis of the subjects discussed. Any market data quoted represents past performance, which is no guarantee of future results. There is no guarantee that any historical trend illustrated herein will be repeated in the future, and there is no way to predict precisely when such a trend will begin. There is no guarantee that any outlook made in this commentary will be realized. Readers should understand that investing involves risk, and loss of principal is possible. Investments in real estate companies and/or housing industry companies involve unique risks, as do investments in ETFs. The information presented does not reflect the performance of any fund or other account managed or serviced by Hoya Capital Real Estate. An investor cannot invest directly in an index, and index performance does not reflect the deduction of any fees, expenses, or taxes. Hoya Capital Real Estate and Hoya Capital Research & Index Innovations have no business relationship with any company discussed or mentioned and never receive compensation from any company discussed or mentioned. Hoya Capital Real Estate, its affiliates, and/or its clients and/or its employees may hold positions in securities or funds discussed on this website and in our published commentary. A complete list of holdings and additional important disclosures is available at www.HoyaCapital.com.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Analyst’s Disclosure:I/we have a beneficial long position in the shares of TSM either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-12 13:135mo ago
2025-10-12 09:015mo ago
LNTH INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lantheus To Contact Him Directly To Discuss Their Options
If you suffered losses in Lantheus between February 26, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) and reminds investors of the November 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
According to the complaint, defendants provided investors with misleading statements concerning the true state of Pylarify’s competitive position; notably, that Lantheus was not equipped to properly assess the pricing and competitive dynamics for Pylarify, risking Pylarify’s price point, revenue, and overall growth potential. These statements caused Plaintiff and other shareholders to purchase Lantheus’ securities at artificially inflated prices.
Investors began to question the veracity of Defendants’ public statements on May 7, 2025, when Lantheus reported its first quarter results below market expectations with Pylarify’s performance particularly falling short. Then, on August 6, 2025, Lantheus again announced disappointing results and significantly reduced growth expectations for Pylarify, which had fallen 8.3% year-over-year, and slashed fiscal year 2025 growth projections. Defendants attributed the losses to the ongoing competition, impacting Pylarify’s pricing dynamics.
Investors and analysts reacted promptly to Lantheus’ revelations. The price of Lantheus’ common stock declined dramatically. From a closing market price of $72.83 per share on August 5, 2025, Lantheus’ stock price fell to $51.87 per share on August 6, 2025, a decline of about 28.8% in the span of one day.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Lantheus’ conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Lantheus Holdings, Inc. class action, go to www.faruqilaw.com/LNTH or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d516bf4b-fab7-416f-a74a-ea4437d5b4b3
2025-10-12 13:135mo ago
2025-10-12 09:065mo ago
SMLR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Semler Scientific
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Semler Scientific To Contact Him Directly To Discuss Their Options
If you suffered losses in Semler Scientific between March 10, 2021 and April 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Semler Scientific, Inc. (“Semler Scientific” or the “Company”) (NASDAQ: SMLR) and reminds investors of the October 28, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Semler Scientific did not disclose a material investigation by the United States Department of Justice (the “DOJ”) into violations of the False Claims Act, while discussing possible violations of the False Claims (and aggressive DOJ enforcement thereof) in hypothetical terms; and (2) as a result, defendants public statements were materially false and/or misleading at all relevant times.
After trading hours on February 28, 2025, Semler Scientific filed with the SEC its 2024 annual report on Form 10-K. The annual report disclosed that on February 11, 2025, Semler Scientific "began initial settlement discussions with DOJ [(the United States Department of Justice)], but ceased initial discussions on that date. Accordingly, there is a risk that DOJ will file a complaint or complaint in intervention in a civil False Claims Act lawsuit seeking damages. [Semler Scientific] does not believe the amount of loss can be reasonably estimated."
On this news, Semler Scientific's stock fell over 9% on the next trading day.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Semler Scientific’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Semler Scientific class action, go to www.faruqilaw.com/SMLR or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d516bf4b-fab7-416f-a74a-ea4437d5b4b3
2025-10-12 13:135mo ago
2025-10-12 09:085mo ago
JSPR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their Options
If you suffered losses in Jasper between November 30, 2023 and July 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) and reminds investors of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) Jasper lacked the controls and procedures necessary to ensure that the third-party manufacturers on which it relied were manufacturing products in full accordance with cGMP regulations and otherwise suitable for use in clinical trials; (ii) the foregoing failure increased the risk that results of ongoing studies would be confounded, thereby negatively impacting the regulatory and commercial prospects of the Company's products, including briquilimab; (iii) the foregoing increased the likelihood of disruptive cost-reduction measures; (iv) accordingly, the Company's business and/or financial prospects, as well as briquilimab's clinical and/or commercial prospects, were overstated; and (v) as a result, Defendants' public statements were materially false and misleading at all relevant times.
On July 7, 2025, Jasper issued a press release reporting updated data from the BEACON Study. The press release stated that "[r]esults from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed with drug from the lot in question," that "[t]he Company is investigating the drug product lot in question and expects to have the results of that investigation in the coming weeks," and that Jasper was "taking steps to ensure that drug product from the lot in question is returned to the Company and that sites have drug product from other lots to continue dosing." Further, the press release revealed that the Company "has also determined that the drug product lot in question was used to treat participants enrolled in the ETESIAN [Study]. As a result, and in order to focus resources on advancing briquilimab in CSU, the Company is halting the study and pausing development in asthma." Finally, the press release stated that "the Company is halting development in SCID" and, contrary to its prior representation of having a strong balance sheet and a cash runway extending "through the third quarter of 2025," that Jasper "will be implementing a number of other cost cutting measures including a potential restructuring, to extend runway and reduce expenses."
On this news, Jasper's stock price fell $3.73 per share, or 55.1%, to close at $3.04 per share on July 7, 2025.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Jasper’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Jasper Therapeutics, Inc. class action, go to www.faruqilaw.com/JSPR or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d516bf4b-fab7-416f-a74a-ea4437d5b4b3
2025-10-12 12:135mo ago
2025-10-12 06:255mo ago
BlackRock's Playbook: From Index Giant To Growth Powerhouse
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
This media giant has a lot to prove this earnings season.
Satellite radio was cool. Once. Howard Stern's jumping to the platform from terrestrial morning show programming 20 years ago turned heads. Drivers scoring uninterrupted coast-to-coast access to commercial-free music through their dashboards was a game-changer. Auto dealers feeling incentivized to push free trial subscriptions of the novel but bar-raising service made the factory-installed receivers a hot accessory. Sirius XM Holdings (SIRI -5.65%) had it all. It's now squarely a boring stock.
Sirius XM hasn't posted double-digit organic annual revenue growth in more than 10 years. Its subscriber count peaked in 2019. Top-line results are declining for the third year in a row. If this music stock seems like a radio knob slowly fading to zero, you might want to consider pumping up the volume before the end of the month.
Image source: Getty Images.
Earning your respect
Sirius XM's transformation from a high-flying growth investment to a stodgy value stock is easier to explain than to live through. The arrival of the connected car made it easy for anyone with a smartphone to seamlessly stream audio app content through their car stereo system. The pandemic kept our cars parked for too long, diminishing the value of a premium radio subscription. Tastes also evolved coming out of the shelter-in-place phase of the COVID-19 crisis, and Sirius XM failed to court young audiences by clinging to its more seasoned talent.
There are still some pretty good reasons to warm up to this satellite radio monopoly, and that should be evident when Sirius XM reports its third-quarter results on the morning of Oct. 30. Sirius XM is still generating 10-figure annual free cash flow and putting that money to work through buybacks and a dividend currently yielding 4.9%. The shares are trading for under 8 times this year's projected earnings, a rare single-digit multiple for a consumer-facing titan with a still-healthy 33 million subscriber base.
What can Sirius XM offer on Oct. 30 to shift out of reverse on a stock that is down 14% over the past year? It can come through with an earnings beat after falling short on the bottom line in back-to-back quarters. Return to revenue growth. Maybe reiterate the record $1.5 billion in free cash flow it's modeling for 2027. It's already sprucing up its programming with fresh voices, but a little more can't hurt. Sirius XM could have a lot to say this earnings season, and luckily for investors, it has the means to amplify its broadcasts.
Rick Munarriz has positions in Sirius XM. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
2025-10-12 12:135mo ago
2025-10-12 06:305mo ago
Did OpenAI Just Ensure Nvidia Will Be The First $10 Trillion Stock?
The two companies now have a partnership to build massive data centers for artificial intelligence (AI) computing.
Computing capacity is everything. At least, that is what CEO Sam Altman says about OpenAI. The artificial intelligence (AI) disruptor has been signing deals to help finance its increasing need for data centers to run its ChatGPT systems, which are growing rapidly and now have over 700 million weekly active users.
The largest of these deals is with Nvidia (NVDA -4.84%). Nvidia will invest $100 billion incrementally into OpenAI, which will then spend the money on Nvidia chips to build 10 gigawatts or more of AI data centers. This could not only be a lucrative investment for Nvidia, but should lead to a huge revenue boost for the rest of the decade.
Today, Nvidia has the largest market cap in the world, at $4.6 trillion as of this writing. Will this new OpenAI deal catalyze Nvidia to become the world's first $10 trillion stock? Let's take a closer look at the deal and find out.
A $100 billion partnership
On Sept. 22, OpenAI and Nvidia jointly announced a potentially revolutionary strategic partnership. OpenAI is not like the giant cloud providers such as Alphabet, which spent years building infrastructure suited for AI. OpenAI is a large company, but its still not profitable and it needs a ton of capital to make its AI vision come true.
Nvidia is the key supplier of graphics processing units (GPUs) for AI data centers. Without the big tech balance sheets, OpenAI has gotten creative with its financing structure. Nvidia is going to slowly invest around $100 billion into OpenAI, who will then take that cash and build data centers with Nvidia computer chips. This could represent millions of GPUs purchased from Nvidia to build 10 gigawatts of capacity.
It is estimated that current data center capacity in the United States is just over 50 gigawatts. This means the proposed spending from OpenAI utilizing Nvidia GPUs could end up being a 20% boost to the total data center footprint in the United States today. This is a gargantuan scale that should put the $100 billion and 10-gigawatt claims in proper context.
Image source: Nvidia.
Nvidia's revenue potential
The AI data center boom already turned Nvidia into the largest company in the world by market cap. Its revenue over the last 12 months was $165 billion, which it turned into $86.6 billion in bottom-line net income.
OpenAI is not going to add $100 billion to Nvidia's top line in 2026. However, through 2030, it could incrementally add tens of billions to Nvidia's annual revenue figures, which would be impactful versus its $165 billion current level. Remember that OpenAI is not Nvidia's only customer: It sells to the likes of Meta Platforms, Microsoft, and Amazon for their own data center expansion plans.
We shouldn't forget the investment in OpenAI, either. Nvidia's $100 billion investment into OpenAI may not turn into trillions of dollars in value, but it could be quite lucrative if OpenAI turns into a trillion-dollar business itself and Nvidia owns 10% of the company (as an example, 10% isn't an exact figure).
NVDA PE Ratio data by YCharts
Will Nvidia hit $10 trillion?
OpenAI is setting the standard in AI infrastructure spending, and it is not low. Other competitors will need to raise their spending in order to match what OpenAI is building to catch up in the AI race.
All this will lead to more spending on Nvidia computer chips. If the company has a market cap of $4.6 trillion today versus $165 billion in revenue, it will likely need to hit $300 billion in annual revenue or more to hit a $10 trillion value.
Today, Nvidia has a net income margin of 53%. If that margin is maintained with revenue of $350 billion that arrives because of huge spending levels from OpenAI and others, Nvidia will have $185.5 billion in net income at some point within this decade. That would give it an expensive price-to-earnings ratio (P/E) of 54, but that is not far off from Nvidia's current P/E of 53.
It may seem unlikely, but there is a chance that OpenAI's deal spurs Nvidia to reach a market cap of $10 trillion by 2030. Just don't go investing in the stock thinking it is guaranteed to happen tomorrow.
Brett Schafer has positions in Alphabet and Amazon. The Motley Fool has positions in and recommends Alphabet, Amazon, Meta Platforms, Microsoft, and Nvidia. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
2025-10-12 12:135mo ago
2025-10-12 06:325mo ago
Wild Alaskan Company Cuts Snowflake Costs by 48% with Yuki, as Yuki Launches Model‑Level Warehouse Optimization for dbt at Coalesce 2025
LAS VEGAS, Oct. 12, 2025 (GLOBE NEWSWIRE) -- As Wild Alaskan scaled its data platform, Snowflake costs grew unpredictable and required constant manual intervention. With Yuki, the company cut compute waste, stabilized query performance, and gained predictable budgets in under a month.
“Yuki gave us instant cost visibility and optimization, without pulling engineers off product work,” said Crystal Lee, VP of Data Science & Analytics at Wild Alaskan Company. “We’re running a leaner, faster data platform that scales with growth.”
New dbt-Native Model‑Level Warehouse Optimization at Coalesce 2025
At Coalesce, Yuki will debut its dbt-native integration, designed to give analytics engineers direct visibility into cost and performance at the model level. This means:
See costs per model — view runtime, cost, and execution timeline for each dbt model.Tune warehouse sizes per model — scale up or down the compute per model or job run type.Track impact over time — see who changed what, when, and what the cost/runtime deltas were.Adopt an investigate, optimize, verify loop — surface anomalies, adjust models, validate outcomes.
“dbt has become the backbone of modern analytics engineering,” said Amir Peres, Yuki’s CTO. “With our new dbt-native Model‑Level Warehouse optimization, teams can finally connect performance and cost — making FinOps part of the analytics workflow, not an afterthought.”
Availability & Access
This feature is now live for all Yuki customers. Users can access the “dbt” tab in Yuki’s interface to review execution summaries, model timelines, change histories, and initiate warehouse sizing adjustments per model. For more details, visit: https://yukidata.com/blog/dbt-model-level-optimization/
Case Study Spotlight at Coalesce
Yuki will showcase the Wild Alaskan Company case study during Coalesce 2025, sharing how customers cut +40% of Snowflake compute on average with zero engineering effort. Attendees can see a live demo of both the dbt integration and Yuki’s dynamic warehouse optimization platform and get access to Yuki’s latest dbt repo.
About Yuki
Yuki is the real-time optimization platform for Snowflake. Enterprises use Yuki to cut their data costs by automatically right-sizing warehouses, consolidating queries, and forecasting spend. With one-hour onboarding and enterprise-grade governance, Yuki delivers predictable costs without disrupting performance or engineering teams.
For more info visit https://yukidata.com/
NuScale Power is working toward something huge that could potentially change the energy landscape forever.
If you hear the names Chernobyl, Three Mile Island, and Fukushima, you will most likely associate them with nuclear power. But not in a good way, since the notoriety of these names is because of nuclear meltdowns, or near misses.
NuScale Power (SMR -3.37%) is hoping it can change the nuclear power industry for the better by changing the way power plants are built. Not enough people are talking about this company or the nuclear technology change that it is helping develop.
Image source: Getty Images.
The "big" problem with nuclear power
Historically, nuclear power plants have been huge capital investment projects. Nuclear reactors have, so far, been site built, meaning that all of the construction basically takes place where the reactor is going to be located. The projects have also been massive, with nuclear power plants often meant to replace large coal or natural gas power plants.
It isn't uncommon for nuclear reactor projects to be delayed and over budget. For example, the most recent nuclear power plant built in the United States, by regulated utility The Southern Company, was seven years late and cost around $17 billion more than expected. Those are not good construction results, even though Southern will now have access to reliable nuclear power for decades into the future.
Given that backdrop, it is understandable that another company building the same style of nuclear power plant at roughly the same time simply gave up when its project manager, Westinghouse, went bankrupt. Southern, by contrast, took on the role of project manager from Westinghouse, which was also overseeing its reactors, so it could keep its power plant construction going.
Needless to say, the nuclear power industry isn't an easy industry in which to operate. And when things go wrong at a large, site-built nuclear power plant, they can go wrong in a massive way, noting the two meltdowns and one near miss highlighted above. That usually earns the entire industry a black eye despite a generally safe operating history for most nuclear power plants.
NuScale is changing the script by going "small"
This is where NuScale Power comes in, given that it is building small scale modular nuclear reactors (SMRs). These reactors are built in a factory, creating a more uniform product that also benefits from the cost efficiencies offered by an assembly line manufacturing approach.
They are small, so they can be easily transported to where they are needed, located more closely to population centers, and adverse events are expected to be easier to contain. In addition, by including the most modern technology, the safety of NuScale's SMRs is expected to be higher than for older reactors.
To be fair, NuScale isn't the only company working on SMR technology. However, it was "the first SMR to receive U.S. Nuclear Regulatory Commission (NRC) design approval." It is currently the only SMR approved by the NRC, which the company believes gives it a bit of a leg up on the competition. But there's another important piece to the puzzle.
NuScale Power is working with RoPower, a Romanian electricity company, as it makes its final go/no go decision on a new nuclear power plant. That plant could end up being powered by six SMRs provided by NuScale Power that will be linked together. NuScale has already ordered parts that have long construction times for the six SMRs this project would require. But it has those same parts on order for another six reactors as well. In other words, the company is ready to hit the ground running.
The company's stock has risen around 200% or so over the past year. Wall Street clearly isn't ignoring the stock. However, with a final decision from RoPower expected sometime in the next year, NuScale Power could quickly change from a good idea to a real business. Notably, the second SMR sale should be much easier to get than the first, since the ice will have been broken. So NuScale Power could turn into a growth story very quickly.
Watch NuScale, even if you don't buy it
Nuclear power and SMRs aren't things that people talk about every day. But SMRs are a potential game-changing technology in the energy sector, with NuScale Power one of the companies leading the way into the future.
If that is interesting to you, and you are a more aggressive investor, you might want to consider buying before the first sale is inked. But even if you aren't interested in buying NuScale, it's worth learning about the huge energy opportunity that SMRs offer the world.
2025-10-12 12:135mo ago
2025-10-12 06:505mo ago
If I Could Only Buy and Hold a Single Stock, This Would Be It
Alphabet is the one stock I'd own if I could only own one.
If I could only own one stock for the next decade, it would be Alphabet (GOOGL -2.07%) (GOOG -1.99%). The company has dispelled fears that artificial intelligence (AI) is a threat, while its biggest risk around its antitrust case is now behind it. Meanwhile, it probably has one of the best long-term growth setups of any stock out there.
Alphabet's dominance starts with search. Google remains the front door to the internet for billions of people, and that's not changing anytime soon due to the huge distribution advantage the company has. It controls both the world's leading smartphone operating system and web browser in Android and Chrome, respectively, while its search revenue-sharing deal with Apple makes it the default search engine for Safari.
Image source: Getty Images.
Meanwhile, Alphabet is now incorporating AI throughout Google to make its offering even stronger and help drive query growth. With new features like Lens and Circle to Search, Alphabet has found new ways to help people search instead of just typing in text. This is driving more queries, many of which have a shopping intent that feeds into its massive ad network. Meanwhile, AI Overviews and its new AI Mode, which lets users toggle between traditional results and chatbot-style answers, are also driving more engagement.
Google's data advantage also shouldn't be underestimated. The company has decades of user data, as well as videos through YouTube, that it can use to make its Gemini AI models better. Alphabet's strength in multimodal AI is another area of strength that gets overlooked. The Gemini chatbot app has been taking off, largely due to Nano Banana, its newest AI image editor and creator, while Google Veo 3 is a video AI leader.
Alphabet has also spent decades creating one of the most wide-reaching ad networks on the planet. It can handle anything from global campaigns to local merchants. Creating great search and AI products is just half the battle; you need to be able to monetize them, and Alphabet's unmatched ad network puts it light-years ahead of any emerging competition.
To the clouds and beyond
While search is Alphabet's biggest business, it is far from a one-horse pony. Cloud computing has become the company's fastest-growing business. Last quarter, Google Cloud revenue jumped 32% to $13.6 billion, while operating income more than doubled to $2.8 billion. Demand is so strong that Alphabet raised its 2025 capital expenditure (capex) budget by $10 billion to $85 billion to expand data center capacity. Unlike many peers, Google Cloud is vertically integrated from top to bottom. Google is the only company with its own world-class AI model and its own custom chips, called Tensor Processing Units (TPUs), that it's using at scale. Those TPUs provide both cost and performance advantages, especially as workloads shift toward inference rather than training.
Alphabet is also taking AI deeper into the enterprise with its new Gemini Enterprise and Gemini Business subscriptions. These offerings let companies build and deploy AI agents without writing code. The launch includes pre-built agents and access to partner-built ones, all backed by enterprise-grade security features like Model Armor. This positions Google to compete directly with Microsoft and OpenAI for corporate AI spending, and early adopters such as Gap and Virgin Voyages are already reporting measurable productivity gains.
Behind all this, Google Cloud benefits from technology that's hard to replicate. It developed Kubernetes, which is now the standard for containerized apps, and it owns one of the largest private fiber networks in the world, delivering low-latency performance on a global scale. Its pending acquisition of Wiz, meanwhile, will add a best-in-class cloud security platform. Google Cloud may be the third-largest cloud provider by market share, but its technology stack and integration with Gemini give it a differentiated position that could drive outsize growth over the next decade.
In addition to cloud computing, Alphabet also has some promising emerging bets. The one furthest along is Alphabet's robotaxi unit Waymo, which is already operating in multiple U.S. cities and expanding rapidly. If it can lower costs, it could eventually become a huge profit driver for the company. The company's quantum computing team, meanwhile, is also making real progress with its Willow chip, which has shown reduced error rates as it scales.
A cheap stock with big growth ahead
Despite all this, Alphabet's valuation still looks attractive. The stock trades at a forward price-to-earnings (P/E) ratio of roughly 22.5 times projected 2026 earnings, which is a clear discount to its mega-cap AI peers. So, despite the rally in the stock this year, it still is not fully getting the respect it deserves.
Given its valuation, wide moat, growth prospects, and the optionality of its emerging bets in robotaxis and quantum computing, Alphabet is the one stock I'd own if I could only own one stock.
Geoffrey Seiler has positions in Alphabet. The Motley Fool has positions in and recommends Alphabet and Apple. The Motley Fool has a disclosure policy.
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Spotify.
William_Potter/iStock via Getty Images
Seeking Alpha News Quiz
Up for a challenge? Test your knowledge on the biggest events in the investing world over the past week. Take the newest Seeking Alpha News Quiz and see how you stack up against the competition.
With the U.S. government shutdown showing no signs of ending, thus delaying key economic data, and renewed trade war concerns, market participants will get a welcome new catalyst this week in the form of the kickoff of the third quarter earnings season.
Major U.S. banks will be in the spotlight, with the largest one, JPMorgan (JPM), set to announce its results on Tuesday. Joining it will be Goldman Sachs (GS), Wells Fargo (WFC), and Citi (C). On Wednesday, Bank of America (BAC) and Morgan Stanley (MS) will report. Investors will also get financial updates from Johnson & Johnson (JNJ) and American Express (AXP).
Traders will also be cautious after Wall Street experienced its worst selloff since the April tariff shock on Friday. Sentiment took a heavy beating after President Donald Trump accused China of "hostile" export controls on rare earths and said the U.S. would impose an additional 100% tariff on products from the Asian nation. Any further dialogue or back-and-forth between Trump and China will be closely watched.
Earnings
Earnings spotlight: Monday, October 13: Fastenal (FAST). See the full earnings calendar.
Earnings spotlight: Tuesday, October 14: JPMorgan (JPM), J&J (JNJ), Wells Fargo (WFC), Goldman Sachs (GS), BlackRock (BLK), Citigroup (C). See the full earnings calendar.
Earnings spotlight: Wednesday, October 15: Bank of America (BAC), Morgan Stanley (MS), Abbott Laboratories (ABT). See the full earnings calendar.
Earnings spotlight: Thursday, October 16: Charles Schwab (SCHW), Bank of NY Mellon (BK), U.S. Bancorp (USB). See the full earnings calendar.
Earnings spotlight: Friday, October 17: American Express (AXP), State Street (STT). See the full earnings calendar.
Rida Morwa and Will Barton (Beyond Saving) lead a powerhouse team of six seasoned income investors at High Dividend Opportunities (HDO) - Seeking Alpha’s #1 service for dividend and income investing. For nearly a decade, HDO has helped members earn reliable, high single-digit yields through expertly curated model portfolios, real-time buy/sell alerts, dividend tracking tools, and an engaged investor community.
Here’s a look at two of HDO’s latest takes:
Retiring Abroad? Here Are Some Key Considerations (Free write-up) - Retiring abroad is becoming increasingly popular among Americans, with over 760,000 now collecting Social Security benefits overseas. Many are drawn by lower living costs, better healthcare options, and the allure of new experiences. However, retirement abroad involves more than just finding a scenic destination - it requires careful consideration of healthcare access, visa and immigration rules, language and cultural barriers, tax implications, and financial management. Ensuring legal compliance, political stability, and secure housing arrangements is crucial. The article emphasizes that while retiring abroad can be rewarding, it demands thoughtful planning to ensure comfort, safety, and sustainability throughout one’s golden years.
My Top Pick For October Yields 14%: AGNC Investment (Free write up) - Following the Federal Reserve’s 25 bps rate cut, markets reacted with short-term selloffs despite expectations of a rally in rate-sensitive sectors. HDO highlights that this presents long-term opportunities, particularly for AGNC Investment Corp. (AGNC), a mortgage REIT benefiting from lower borrowing costs. While AGNC’s earnings may stay flat in 2025 due to maturing interest rate swaps, sustained rate cuts and improved financing conditions are expected to enhance profitability and potentially lead to dividend growth in 2026. Smith emphasizes patience - declining rates will gradually strengthen AGNC’s income potential, making it an appealing long-term pick for income-focused investors.
Unlock proven high dividend strategies, in-depth research, and real-money insights with a paid trial to HDO - just $59 for your first month. Learn More >>
A favorable macro backdrop could supercharge already impressive growth for this business.
Investing behind powerful secular trends can lead to fantastic results. In the past decade, the growth of companies blending financial services with technology has been a notable development. Many businesses operate in this niche.
But one of them stands out. And its shares have climbed 240% in the past 12 months (as of Oct. 8). Here's why it's still the top fintech stock to buy before the end of 2025.
The Fed's accommodative stance could boost lending activity
The Federal Reserve lowered its benchmark interest rate last month. And there could be more rate cuts on the horizon. For companies that lend money, like SoFi Technologies (SOFI -7.91%), the benefit of a more dovish central bank is clear.
As borrowing costs come down, demand for loans should tick up. This can lead to greater revenue potential. SoFi's total loan originations are already growing at a brisk pace, up 66% in Q2 (ended June 30). They could go higher in the near term.
SoFi shares aren't cheap, but the earnings trajectory makes up for it
At a forward price-to-earnings (P/E) ratio of 47.2, on the surface, SoFi shares do not look cheap. And for investors looking at the stock for the first time, it can be disheartening knowing that the forward P/E multiple has expanded considerably in the last six months.
Consider, though, that SoFi's diluted earnings per share jumped by 367% in the second quarter. And analysts expect a similar trend in the years ahead.
Neil Patel has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
2025-10-12 12:135mo ago
2025-10-12 07:015mo ago
GES STOCK NEWS: Guess?, Inc. Announces $16.75 Merger with Authentic Brands – Contact BFA Law about its Ongoing Investigation into the Board
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Guess?, Inc.’s (NYSE: GES) board of directors and executive officers for potential breaches of their fiduciary duties to shareholders in connection with its pending sale to Authentic Brands Group LLC (“Authentic”) for $16.75 per share.
If you are a current shareholder of Guess, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/guess-inc.
Why is Guess being Investigated?
Guess is a fashion retailer with global distribution and sales operations, including over 1,500 directly operated retail stores and distribution operations in approximately 100 countries. Guess was founded in 1981 by the Marciano family, who still own a significant portion of the Company’s stock. One of the founders, Paul Marciano, still sits on the Board and serves as the Chief Creative Officer of the Company.
Paul Marciano, along with other investors including Maurice Marciano (another founder who no longer serves on the Company’s board of directors) have negotiated to rollover their ownership in Guess to own up to 49% of the new intellectual property holding company post-closing, and 100% of the operating company post-closing.
BFA Law is investigating whether Guess’ board of directors, its executive officers, and/or any of the stockholders participating in the rollover have breached fiduciary duties to the stockholders in connection with the merger.
Click here for more information: https://www.bfalaw.com/cases/guess-inc.
What Can You Do?
If you are a current holder of Guess you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
https://www.bfalaw.com/cases/guess-inc
Attorney advertising. Past results do not guarantee future outcomes.
2025-10-12 12:135mo ago
2025-10-12 07:035mo ago
MOH STOCK NEWS: Molina Healthcare, Inc. Shares Dropped 16%; BFA Law Reminds Investors that the Securities Fraud Class Action Could Allow them to Recover Losses
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Molina Healthcare, Inc. (NYSE: MOH) and certain of the Company’s senior executives for potential violations of the federal securities laws.
If you invested in Molina, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/molina-healthcare-inc-class-action.
Investors have until December 2, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Molina securities. The case is pending in the U.S. District Court for the Central District of California and is captioned: Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461.
Why Was Molina Sued Under the Federal Securities Laws?
Molina is a health insurance company that provides managed healthcare services to low-income individuals under Medicaid and Medicare programs. During the relevant period, Molina stated that the Company’s “earnings growth profile” was “solid heading into 2025.” The Company also told investors that it “continuously monitor[ed] utilization patterns” and that it was able to “mitigate the negative effects of healthcare cost inflation.” In truth, as alleged, Molina faced increased medical costs pressures that it could not mitigate due to increased utilization in all three of its business lines.
The Stock Declines as the Truth Is Revealed
On July 7, 2025, Molina revealed that its Q2 2025 adjusted earnings were approximately $5.50 per share, which was “below its prior expectations” due to “medical cost pressures in all three lines of business.” The Company announced it “expects these medical cost pressures to continue into the second half of the year” and cut guidance for expected adjusted earnings per share by 10.2% at the midpoint to a “range of $21.50 to $22.50 per share.”
Then, on July 23, 2025, Molina revealed that it “now expects its full year 2025 adjusted earnings to be no less than $19.00 per diluted share.” Molina stated this was due to a “challenging medical cost trend environment,” including increased “utilization of behavioral health, pharmacy, and inpatient and outpatient services.” On this news, the price of Molina stock fell $32.03 per share, or 16.8%, from $190.25 per share on July 23, 2025, to $158.22 per share on July 24, 2025.
Click here for more information: https://www.bfalaw.com/cases/molina-healthcare-inc-class-action.
What Can You Do?
If you invested in Molina you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
Attorney advertising. Past results do not guarantee future outcomes.
2025-10-12 12:135mo ago
2025-10-12 07:065mo ago
JEF STOCK NEWS: Jefferies Financial Group Inc. Shares Dropped 8%; BFA Law Notifies Investors that its Securities Fraud Investigation Could Allow them to Recover Losses
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital for potential violations of the federal securities laws.
If you invested in Jefferies or Point Bonita, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/jefferies-financial-group-inc-class-action.
Why are Jefferies and Point Bonita being Investigated?
Jefferies is an investment banking and capital markets firm. Its trade finance arm is named Point Bonita Capital. Jefferies and Point Bonita were two of the closest banking and financing partners of First Brands Group, LLC, an auto parts supplier which collapsed into bankruptcy in September 2025.
On October 8, 2025, Jefferies announced that it and Point Bonita had approximately $715 million in exposure to First Brands’ receivables, which represents roughly 25% of Point Bonita’s trade finance portfolio. On this news, the price of Jefferies stock fell $4.66 per share, or about 8%, from $59.10 per share on October 7, 2025, to $54.44 per share on October 8, 2025. Investors are reportedly currently seeking redemptions from Point Bonita as well.
BFA is currently investigating whether Jefferies and/or Point Bonita made materially false and misleading statements to investors in connection with this significant exposure to First Brands.
Click here for more information: https://www.bfalaw.com/cases/jefferies-financial-group-inc-class-action.
What Can You Do?
If you invested in Jefferies or Point Bonita you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
Lockheed's F-35 fighter jet is more popular than ever, but falling prices may be taking a toll on profits.
Valued at almost $120 billion, with nearly $72 billion in annual revenue yielding $4.2 billion in annual profit, Lockheed Martin (LMT -0.53%) remains the most valuable pure-play defense stock in the world. (Although if you look at market capitalization exclusively, one could argue Palantir (PLTR -5.39%) is even bigger, despite boasting much smaller revenues.)
Best known for its military aircraft, in 2024 Lockheed delivered 90 helicopters to its several customers, 21 C-130J transport aircraft, 16 F-16s, and 110 F-35 Lightning II stealth fighter jets. With every passing year, and F-35 production continuing to ramp, Lockheed Martin is transforming itself into an F-35 company.
And perhaps next year more so than ever.
Lockheed's $24 billion F-35 sale
Last week, Lockheed was able to squeeze in one final big F-35 fighter jet sale before the U.S. government shut down. On Sept. 30, the U.S. Air Force announced it will pay Lockheed $24.3 billion to acquire a total of 296 F-35s, in two production lots sized at 148 jets each.
These are staggering numbers, and yet, they're not the numbers that caught my eye.
In a Pentagon contract announcement describing the sale, it was stated that each of the two production "lots" covered by the contract will include a mix of F-35 variants. F-35A, the cheapest variant of the aircraft, will make up the bulk of the purchases -- 105 aircraft in each lot, for a mix of both U.S. Air Force and foreign buyers. But each lot will also include a handful of more expensive F-35B vertical takeoff and landing aircraft, and more than a dozen aircraft carrier-capable F-35Cs as well.
Yet the total purchase cost of all these planes averages out at barely $82 million each.
From $120 million to $80 million
Why is this significant? Consider that just a few years ago, the average cost of even a relatively "cheap" F-35A was about $100 million, while F-35Bs and F-35Cs were costing $120 million and up. In less than a decade -- a decade of rip-roaring inflation rates -- the average cost across all variants has now come down roughly 25%.
These are some pretty significant cost savings. What's really interesting, though, is that they're actually right in line with predictions Lockheed Martin made more than a decade ago -- that F-35s might cost $120 million on average initially, but would come down in price to about $80 million over time, as economies of scale and efficiencies of production began to kick in.
That time has come.
How much is $24.3 billion worth (for Lockheed Martin)?
Cheaper F-35s seems like obviously good news for the Pentagon, and for U.S. taxpayers. But what does it mean for Lockheed Martin? Are company profit margins going to take a hit from all the price-discounting on the F-35?
The short answer appears to be "yes."
Over the three-year period from 2021 through 2023, Lockheed Martin's aeronautics division, which builds the F-35, averaged a little over $27 billion in annual revenue, and earned 10.4% operating profit margins on those sales. In 2024, revenues rose to $29 billion as F-35 sales surged, but profit margins on those sales slumped to 8.6%, according to data from S&P Global Market Intelligence.
Here at the halfway mark of 2025, the story looks even worse -- albeit with a twist.
With H1 revenue of $14.7 billion, Lockheed's aeronautics division appears likely to score about $29 billion in sales again this year, so increased volumes of F-35s sold are offsetting lower prices on those F-35s, such that revenue is still rising. Operating profits so far, however, are only $622 million -- a meager 4.2% profit margin.
Granted, Lockheed blamed its poor showing so far this year primarily on a big "$950 million loss on a classified program" -- which inconveniently for us, was located within the same aeronautics segment that builds the F-35. That makes it hard to blame cheaper F-35 prices for all of Lockheed's falling profit margins. But at the very least, we can say that F-35 margins weren't robust enough to offset losses on the classified program.
Is Lockheed Martin stock a buy?
As a defense stock writer, I'd really like to be able to close out this column telling you Lockheed stock is a buy -- but Lockheed Martin isn't making it easy. Priced at 28.5 times trailing earnings today but with a long-term estimated earnings growth rate of barely 12%, Lockheed stock sells for a PEG ratio of more than 2.0 -- twice as much as what a value investor ordinarily wants to pay for a stock.
Despite the success of F-35, and despite Lockheed Martin delivering on its promises to make the fighter jet more affordable, it's Lockheed Martin's stock price that's the bigger issue today. Until Lockheed Martin stock gets cheaper, I just cannot call it a buy.
Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool recommends Lockheed Martin. The Motley Fool has a disclosure policy.
2025-10-12 12:135mo ago
2025-10-12 07:085mo ago
CHTR STOCK NEWS: Charter Communications, Inc. Shares Dropped 18%; BFA Law Reminds Investors that the Securities Fraud Class Action Could Allow them to Recover Losses
NEW YORK, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Charter Communications, Inc. (NASDAQ: CHTR) and certain of the Company’s senior executives for potential violations of the federal securities laws.
If you invested in Charter, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/charter-communications-inc-class-action-lawsuit.
Investors have until October 14, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Charter securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Sandoval v. Charter Communications, Inc., No. 1:25-cv-06747.
Why Was Charter Sued Under the Federal Securities Laws?
Charter is a leading broadband, or high-speed internet, connectivity company and cable operator. Charter participated in the FCC’s Affordable Connectivity Program (“ACP”), which provided funding to Charter in exchange for subsidizing high-speed internet plans for low-income households. In June 2024, lack of federal funding caused the ACP to end, which led to customer declines at Charter.
During the relevant period, Charter told investors that the Company was executing a plan to minimize and move beyond risks that the end of the ACP had on customer declines and earnings. The Company stated that it had “managed the end of the affordable connectivity program successfully” and that “[t]he impact of the elimination of the ACP is now behind us.” As alleged, in truth, the impact from the ACP’s elimination was not behind Charter as the Company continued to experience internet customer and revenue declines from the program’s end.
The Stock Declines as the Truth Is Revealed
On July 25, 2025, Charter announced its second quarter 2025 financial results. The Company reported that total internet customers decreased by 117,000 during the quarter, which included approximately 50,000 disconnects related to the end of the ACP, nearly double from the prior quarter. On this news, the price of Charter stock declined $70.25 per share, or 18.4%, from a closing price of $380.00 per share on July 24, 2025, to $309.75 per share on July 25, 2025.
Click here for more information: https://www.bfalaw.com/cases/charter-communications-inc-class-action-lawsuit.
What Can You Do?
If you invested in Charter you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
Analyst’s Disclosure:I/we have a beneficial long position in the shares of PEP either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-12 12:135mo ago
2025-10-12 07:205mo ago
Every Apple (AAPL) Investor Should Keep an Eye on This Number
Hardware gets all the attention, but Apple's business depends on success in another area.
Apple (AAPL -3.40%) sells some of the most admired products on the face of the planet. Its iPhone, a device in the 18th year of its lifecycle, is still so successful that it generated $44.6 billion in revenue in the third quarter (ended June 28). Add this to more items in the lineup, and it's no surprise this business is a consumer favorite.
Without a doubt, hardware is important to Apple's success. But here's a number that every shareholder should keep an eye on.
Apple's services are a critical component of the business
Investors should be paying close attention to revenue trends within Apple's services segment.
During the third quarter, services, which include advertising, cloud, Music, Pay, and TV+ (among others), raked in $27.4 billion in sales, up 13% year over year. This revenue figure was 108% higher than the same period five years ago, a much faster pace of growth than the products division.
Services introduce recurring revenue, allowing the company to lower dependence on less predictable hardware sales. Services are also significantly more profitable, with a gross margin that's above 70%.
"We have well over 1 billion paid subscriptions across the Services on our platform," CFO Kevan Parekh said on the Q3 2025 earnings call. Ongoing success in services means that Apple's ecosystem is in strong shape, as users are increasingly interacting with its devices. This supports the company's economic moat.
Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Apple. The Motley Fool has a disclosure policy.
SummaryAmplify Alternative Harvest ETF has a history of underperformance and recent gains driven by speculative cannabis sector optimism.MJ's portfolio is concentrated in both U.S. MSOs and Canadian LPs, with heavy exposure to stocks currently rated Sell or Strong Sell.Despite recent outperformance versus peers, MJ's index construction and lack of ancillary exposure make it unattractive compared to alternatives like CNBS.I recommend selling MJ, favoring CNBS, or select individual cannabis stocks and ancillaries for better risk/reward in the current market.Looking for a portfolio of ideas like this one? Members of 420 Investor get exclusive access to our subscriber-only portfolios. Learn More » Maria Vonotna/iStock via Getty Images
I have been covering cannabis stocks for more than a dozen years, and I remember when Amplify Alternative Harvest ETF (NYSEARCA:MJ) came out in late 2017. It had a different name then, as I discuss
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
2025-10-12 12:135mo ago
2025-10-12 07:305mo ago
These 2 Cryptocurrency Stocks Are Riding Bitcoin's Record Highs
Bitcoin may be soaring, but these crypto stocks are doing even better.
This October has been good for cryptocurrencies so far. As I write this (Oct. 8), Bitcoin (CRYPTO: BTC) has gained 7% since the start of the month and 10% in the past 30 days. One driver was the government shutdown, which increased the appeal of alternative assets like crypto and gold that may act as safe havens.
Strong crypto performance is usually good news for cryptocurrency stocks and Bitcoin corporate treasury companies. Indeed, these two have outperformed Bitcoin in the past month.
Image source: Getty Images.
1. Bullish
Bullish (BLSH -9.44%) has gained almost 35% in the past 30 days, buoyed by several announcements. The institution-focused global digital asset platform launched a U.S. spot trading exchange and a crypto options platform for clients outside the U.S.
It also announced a corporate banking partnership with Deutsche Bank (NYSE: DB) that includes fiat deposits and withdrawals for clients in Hong Kong and Germany.
2. MARA Holdings
MARA Holdings (MARA -7.67%) is up over 30% in the past 30 days. It reported that September's Bitcoin production was up 4% month over month and showed it is taking a higher proportion of overall miner rewards.
MARA is a Bitcoin mining company with a twist: It reduces the cost of mining through renewable energy generation and clean energy conversion. It's also expanding into AI data centers, making it more than a one-trick Bitcoin pony.
Bitcoin corporate treasury companies can be risky
There are various ways to get exposure to Bitcoin, including buying it directly, investing in Bitcoin ETFs, and using corporate treasury companies. For some -- like the two above -- Bitcoin is a core part of their business.
For others, like Strategy (NASDAQ: MSTR), Bitcoin accumulation sits outside their original business activities. Strategy has led the way in using leverage, which can generate outsized returns. However, that also adds risk.
If you're considering investing in a Bitcoin treasury company, take a good look at the role crypto plays in their business. Consider how much Bitcoin it holds, what it paid for it, and how the business will handle any prolonged price drops.
Emma Newbery has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Bitcoin. The Motley Fool has a disclosure policy.
2025-10-12 12:135mo ago
2025-10-12 07:305mo ago
FLJP: Political Turmoil Is A Concern For Japanese Markets
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-12 12:135mo ago
2025-10-12 07:355mo ago
Top Wall Street analysts are bullish on these 3 stocks for the long term
Investors are looking beyond the prolonged U.S. government shutdown and remain optimistic about growth drivers like the artificial intelligence boom and expectations of further interest rate cuts.
Ignoring the short-term noise, those looking for attractive investment opportunities can consider the stock picks of top Wall Street analysts, whose recommendations are based on a thorough analysis of a company's fundamentals and growth catalysts.
Here are three stocks favored by the Street's top pros, according to TipRanks, a platform that ranks analysts based on their past performance.
SnowflakeFirst on this week's list is Snowflake (SNOW), a cloud-native data platform. At the recently held Snowflake World Tour event in New York City, the company highlighted its product innovation and the vision for driving business transformation through data and artificial intelligence.
After attending this customer conference, Jefferies analyst Brent Thill reiterated a buy rating on SNOW stock with a price forecast of $270. Based on his conversations with customers and partners at the event, the analyst noted that Snowflake's product innovation and velocity are accelerating.
Thill highlighted that while traction for Snowflake's AI offerings is building, the inflection point is still ahead. For instance, the top-rated analyst noted that a retailer using Snowpark ML for demand forecasting, and a travel company integrating Snowflake ML models into its customer experience pipeline, both believe that broader usage across their organizations will take a few more quarters.
Another key takeaway was that Snowflake's unstructured data capabilities have strengthened, but there are still some gaps to address. Overall, Thill believes that while traction is building for Snowflake, the "AI Blizzard" still lies ahead.
"SNOW remains one of our favorite data & AI stories and stands to benefit meaningfully as enterprise AI strategies mature and AI driven data volumes grow exponentially in the coming years," concluded Thill. Interestingly, TipRanks' AI Analyst has a "neutral" rating on Snowflake stock with a price target of $255.
Thill ranks No. 251 among more than 10,000 analysts tracked by TipRanks. His ratings have been successful 65% of the time, delivering an average return of 14.1%. See Snowflake Ownership Structure on TipRanks.
Advanced Micro DevicesMoving on to chipmaker Advanced Micro Devices (AMD), which recently made headlines after announcing a game-changing partnership with OpenAI. Under this deal, OpenAI will deploy up to 6 gigawatts of AMD Instinct GPUs over multiple years, starting with a 1-gigawatt rollout in the second half of 2026. The agreement also involves a warrant for up to 160 million shares (vesting tied to certain milestones), which, if fully exercised by OpenAI, will give it about a 10% stake in AMD.
Following the news, Jefferies analyst Blayne Curtis upgraded AMD stock to buy from hold and boosted the price target to $300 from $170. Additionally, TipRanks' AI Analyst has an "outperform" rating on AMD stock with a price target of $232.
Curtis believes that AMD's deal with OpenAI clearly changed the AI narrative for the semiconductor company. While the chipmaker will still have to achieve some milestones, the 5-star analyst believes that this partnership is a solid confirmation of AMD's AI roadmap and a proof of robust AI demand in general.
Interestingly, Curtis recently raised his estimates for AMD following positive server checks. The analyst stated he was incrementally positive on AMD after his recent Asia trip, with the expectation of 500 basis points per year share gains in server CPUs with the company's Venice platform.
However, these recent checks hadn't helped Curtis grasp anything from the original device manufacturers (ODMs) in terms of AI ramps. "The announcement of OpenAI as a lead customer with the potential for $80-100B in revenue across 6GW of compute through 2030 materially changes that outlook," said Curtis.
Curtis ranks No. 68 among more than 10,000 analysts tracked by TipRanks. His ratings have been profitable 65% of the time, delivering an average return of 27.5%. See AMD ETF Exposure on TipRanks.
Dell TechnologiesIT infrastructure and personal computing solutions provider Dell Technologies (DELL) announced an increase in its long-term financial targets during its analyst meeting on Oct. 7. The improved outlook is backed by demand from the ongoing AI wave.
Following the event, Mizuho analyst Vijay Rakesh reiterated a buy rating on DELL stock and raised his price target to $170 from $160. Meanwhile, TipRanks' AI Analyst has a "neutral" rating on DELL stock with a price target of $135.
Rakesh noted management's commentary about momentum in enterprise and sovereign AI, with strong demand signals over 12-18 months. The top-rated analyst highlighted that the company raised its compound annual growth rate target for revenue for fiscal 2026 to 2030 to the range of 7% to 9%, with non-GAAP EPS expected to rise by 15% or more.
Furthermore, Rakesh noted that Dell's fiscal 2026 AI server revenue estimate of $20 billion is in line with the Street's consensus of $20.6 billion and reflects over 100% growth from $9.8 billion in the previous year. The company expects a 20% to 25% CAGR through Fiscal 2030, implying AI server revenue of $46 billion.
However, the analyst believes that this growth outlook could be conservative, as the company is involved in all at-scale AI cluster deployments and leads in T2 CSP (tier 2 cloud service providers) and enterprise AI deployments with more than 3,000 customers.
Rakesh ranks No. 81 among more than 10,000 analysts tracked by TipRanks. His ratings have been successful 65% of the time, delivering an average return of 24.3%. See Dell Technologies Hedge Fund Activity on TipRanks.
2025-10-12 12:135mo ago
2025-10-12 07:385mo ago
Enterprise Products Partners: Profiting From Ethane Demand Growth, But Not Cheap
SummaryEnterprise Products Partners offers a 6.97% yield, strong balance sheet, and 27-year track record of distribution growth, appealing to conservative income investors.EPD's cash flows remain stable despite declining crude oil prices, as its diversified asset base and focus on natural gas liquids position it for future growth.The company is expanding with new processing plants and the Bahia Pipeline, capitalizing on rising global demand for ethane and natural gas liquids exports.While EPD trades at a premium to peer MLPs, its stability, distribution growth, and resilience to commodity price swings justify its valuation for long-term investors.This idea was discussed in more depth with members of my private investing community, Energy Profits in Dividends. Learn More »onurdongel/iStock via Getty Images
Enterprise Products Partners L.P. (NYSE:EPD) is a midstream master limited partnership that transports crude oil and natural gas all over most of the continental United States, except for the West Coast:
As we can see in
Analyst’s Disclosure:I/we have a beneficial long position in the shares of MPLX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
This article was originally published to Energy Profits in Dividends at 3:15 p.m. EST on October 10, 2025. Subscribers to the service have had since that time to act on it.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
2025-10-12 12:135mo ago
2025-10-12 07:415mo ago
3M: Lifting My Price Target Into Earnings, Shares Hit Key Support
Summary3M (MMM) remains a core Industrials blue chip, delivering an 85% total return since October 2022, but currently trades near fair value.Q2 results were strong, with EPS and revenue beats, margin improvement, and raised guidance, though shares fell post-earnings.MMM's earnings outlook is steady, with high single-digit EPS growth expected and positive sellside sentiment, but tariff and inflation risks persist.I reiterate a hold rating on MMM, as technicals are mixed and valuation is fair, with potential upside if tariff risks abate. jetcityimage/iStock Editorial via Getty Images
The bull market turned three years old this past weekend. The S&P 500’s gain, including dividends, is 89% over that timeframe. While five of the 11 S&P 500 sector ETFs have compounded annualized growth rates below 10%, the Industrials sector
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
2025-10-12 12:135mo ago
2025-10-12 07:455mo ago
The Best Vanguard ETF to Invest $1,000 in Right Now
Investing in passive vehicles can produce fantastic results for patient investors.
One of the most effective ways investors can put money to work in the stock market is not necessarily to go the active route and pick individual stocks. Instead, finding passive vehicles, such as exchange-traded funds (ETFs), can be a phenomenal way to position your portfolio for lasting success.
While there are many of these products on the market, investors might want to focus on those offered by Vanguard, a massive asset management firm that handles $11 trillion (as of July 31) and has been leading the industry for decades. It has a reputation for putting its clients' needs first, and investors don't need a large sum of capital to start.
Along the same vein, here's the best Vanguard ETF to buy with $1,000 right now.
Image source: Getty Images.
This ETF gives investors exposure to the S&P 500
There's no question that the S&P 500 is the bellwether index, with a total market capitalization of $52 trillion. It's viewed as the premier gauge of how the stock market performs, as it contains 500 large and profitable U.S. companies. Many investors are certainly familiar with it.
Putting $1,000 to work in an ETF that tracks the S&P 500, such as the Vanguard S&P 500 ETF (VOO -2.69%), is a smart move by investors. Investors immediately achieve broad diversification without having to individually buy 500 different stocks. All sectors of the economy are represented, from technology and financial services to energy and consumer staples. Owning this ETF means investors are placing a bet that the American economy will continue on its path of innovation and growth. Historically, this has been the right call.
By buying the Vanguard S&P 500 ETF, investors also ensure they have exposure to the powerful artificial intelligence (AI) trend, which has been the key theme in the stock market in recent years. Trying to pick the winners early on can seem like a daunting task. This ETF will make sure there are a number of AI-powered businesses in the portfolio.
Investors likely care most about performance and fees
The first thought that investors considering an ETF might have is that the fund won't produce adequate returns, at least not the same type of gains that come from picking individual stocks. This perspective is flawed, as the Vanguard S&P 500 ETF shows.
In the past decade, this ETF has generated a total return of 304% (as of Oct. 7). Had you invested $1,000 in it in October 2015, you'd have $4,043 today. This is a fantastic result.
What makes the situation even better is the low cost of owning the ETF. The Vanguard S&P 500 ETF carries an ultra-cheap expense ratio of just 0.03%. So, from a $1,000 asset base, only $0.30 goes to Vanguard in the form of fees on an annual basis. This helps to cover the firm's various operational costs. It's hard to beat the value proposition.
Data shows that the vast majority of active fund managers, professionals who are viewed as experts in the world of finance and investing, lag the S&P 500's performance over a 10-year time horizon. However, that poor showing does not prevent them from charging fees that are well in excess of what the Vanguard S&P 500 ETF charges.
Future returns might not resemble the past
It would be wonderful if the Vanguard S&P 500 ETF generated the same kind of return over the next decade that it did in the past 10 years. If this were the case, then perhaps it's a better idea to put much more than $1,000 to work if possible, depending on your personal finances.
But the truth is that no one knows what the future will hold, as returns could be higher or lower depending on various factors. Regardless, what matters is that investors act now and put money to work, as patience will be rewarded.
Neil Patel has positions in Vanguard S&P 500 ETF. The Motley Fool has positions in and recommends Vanguard S&P 500 ETF. The Motley Fool has a disclosure policy.
2025-10-12 12:135mo ago
2025-10-12 07:595mo ago
Gold Extends Bullish Momentum as Trade Tensions Escalate and Growth Weakens
Gold Surge as U.S.–China Trade Tensions Escalate
The trade crisis between the United States and China intensified. China expanded its export controls on rare earth elements, adding five new materials and tightening scrutiny on semiconductor users. The move came just two weeks before a planned meeting between President Xi Jinping and President Donald Trump at the APEC summit in South Korea.
Beijing’s latest restrictions also target refining technologies and impose compliance requirements on foreign producers using Chinese materials. The U.S. administration quickly retaliated with new tariffs and technology export limits, reigniting fears of a broader trade confrontation.
President Trump described China’s move as a “real surprise” and questioned whether the upcoming meeting should proceed. This escalation rattled global markets, boosting demand for traditional safe-haven assets.
Trump’s Tariffs Shake Markets as Treasury Yields Drop
After markets closed on Friday, President Trump announced a 100% tariff on imports from China and new controls on any critical software. The announcement sent shockwaves through financial markets. Treasury yields dropped sharply, and the US dollar weakened, signalling renewed risk aversion among investors.
The chart below shows that the 10-year Treasury yield is approaching long-term support near 4.0%. This reflects expectations that investors will shift toward safer assets. Moreover, the inflation remains sticky at 3.0%, and a balanced yield curve would keep short-term rates near 4.0%.
The falling expectations, rising inflation concerns, and trade war fears have collectively weighed on household optimism. This erosion in confidence supports continued demand for defensive assets such as gold and silver (XAG), while risk appetite across equities remains fragile.
Trade War and Fiscal Expansion Fuel Inflation
The U.S. and China are now caught in a modern version of the “Thucydides Trap,” where a leading power and a rising rival are likely to clash. A direct war is unlikely, but both countries are using economic pressure to compete for global control.
The U.S. holds a military advantage, but China’s strength in manufacturing and resources gives it strategic leverage. Trump’s transactional style contrasts with Beijing’s long-term planning, adding uncertainty to how this economic standoff will play out.
The consequences will include larger fiscal spending programs, suppressed interest rates, and persistent inflation. These conditions have historically favored precious metals. The shift away from U.S. Treasuries toward gold as a global reserve hedge may accelerate as investors seek protection from policy instability.
Gold’s Parabolic Uptrend Strengthens Amid Geopolitical and Economic Uncertainty
Long-Term Momentum Builds as Gold Extends Its Multi-Year Bullish Trend
Gold has been trading in a parabolic uptrend for several decades, and this move has intensified over time. The yearly chart below shows that gold formed a major bottom in 2015, which triggered a strong upward surge.
Since then, prices have continued to advance each year, with bullish momentum accelerating after 2022. Gold gained around 13% in 2023 and more than 27% in 2024. This momentum was further increased in 2025 as the price had gained over 50% by October 2025.
This move would likely coincide with a strong rally in silver prices, possibly breaking above the key $50 level. This breakout in silver would support continued strength in the gold market as well, potentially driving gold prices higher and reinforcing the long-term momentum toward the $10,000 region.
Market Risks: Inflation, Policy Shifts, and Geopolitical Tensions Threaten Stability
Trade tensions between the U.S. and China may escalate further. Any breakdown in diplomatic talks or additional retaliatory measures could disrupt global supply chains and trigger sharp market reactions. Sudden policy changes, such as tariff increases or export restrictions, may create uncertainty and short-term volatility across commodity and equity markets.
The Federal Reserve faces a dilemma. Cutting rates to support growth may worsen inflation. However, holding rates steady could risk a deeper slowdown. The sticky inflation near 3.0% and rising fiscal spending may pressure bond markets and undermine confidence in monetary policy. This environment may fuel demand for gold, but it also increases the risk of financial instability.
Moreover, the falling consumer sentiment signals weak household confidence in the economy. If inflation stays elevated and wage growth remains soft, spending may decline. At the same time, political tensions ahead of the 2026 midterm elections could limit the government’s ability to respond effectively. These overlapping risks could hurt corporate earnings and lead to broader market stress, even as gold benefits.
Final Thought: Safe-Haven Demand and Trade Tensions Support Bullish Momentum
Gold continues to benefit from rising geopolitical and economic uncertainty. The escalation of the U.S.–China trade war, persistent inflation, and weakening consumer sentiment all support a defensive investment stance. Precious metals offer protection as policy risks and market volatility increase.
The long-term chart for gold shows a parabolic move, with prices rising steadily while respecting key short-term resistance levels. This surge reflects strong buying driven by geopolitical tensions and may extend toward the long-term target of $10,000. Investors may continue to buy on dips to capture potential new highs, as the strong yearly candle for 2025 suggests even greater momentum in 2026.
As global power struggles and fiscal expansion reshape the economic landscape, gold remains a key asset for preserving value and managing risk.
2025-10-12 12:135mo ago
2025-10-12 08:005mo ago
HTD: A Reliable Income Payer For Conservative Investors: Utilities Exposure And 7.7% Yield
SummaryThe John Hancock Tax-Advantaged Dividend Fund is a closed-end fund that invests globally in equities and preferred securities of U.S. and non-U.S. companies.What makes this fund attractive for income investors is that it has been a consistent payer of income that has rarely been reduced. Also, it provides decent growth over the long term.For existing holders and conservative income investors, HTD is a solid 'hold' for a reliable stream of income and decent growth. New investors should accumulate on a dollar-cost-average basis. Khanchit Khirisutchalual/iStock via Getty Images
Introduction: John Hancock Tax-Advantaged Dividend Fund (NYSE:HTD) was launched in February 2004 as a closed-end fund. The fund's primary objective is to provide a high level of after-tax income. Capital appreciation is the secondary objective. It
Analyst’s Disclosure:I/we have a beneficial long position in the shares of ABT, ABBV, CI, JNJ, PFE, NVS, NVO, AZN, UNH, CL, CLX, UL, NSRGY, PG, TSN, ADM, BTI, MO, PM, KO, PEP, EXC, D, DEA, DEO, ENB, MCD, BAC, PRU, UPS, WMT, WBA, CVS, LOW, AAPL, IBM, CSCO, MSFT, INTC, T, VZ, CVX, XOM, VLO, ABB, ITW, MMM, LMT, LYB, RIO, O, NNN, WPC, ARCC, ARDC, AWF, BME, BST, CHI, DNP, QQQX, USA, UTF, UTG, TLT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Disclaimer: The information presented in this article is for informational purposes only and in no way should be construed as financial advice or a recommendation to buy or sell any stock. The author is not a financial advisor. Please always do further research and do your own due diligence before making any investments. Every effort has been made to present the data/information accurately; however, the author does not claim 100% accuracy. The stock portfolios presented here are model portfolios for demonstration purposes. For the complete list of our LONG positions, please see our profile on Seeking Alpha.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Recommended For You
2025-10-12 11:135mo ago
2025-10-12 05:005mo ago
Bitcoin Apparent Demand Turns Negative — What This Means For Price
Bitcoin prices are consolidating around $111,000 following the heavy market losses on October 10, due to a trade war between the US and China. The asset’s price is presently down by 9.45% on its weekly chart and also 12.16% away from its all-time high amidst this corrective phase.
Bitcoin Logs First Negative Apparent Demand Flip Since July
In an X post on October 11, popular market analyst Ali Martinez shares on-chain data that shows that Bitcoin’s apparent demand has recently flipped into negative territory for the first time in three months, suggesting a short-term cooling in investors’ appetite.
For context, the apparent demand measures the net amount of Bitcoin being accumulated by active holders. In simpler terms, it reflects how much of the Bitcoin supply is being reactivated or moved relative to how much is newly created. A positive reading generally indicates growing market demand and accumulation, while a negative value suggests reduced appetite or selling pressure.
Data from on-chain analytics firm CryptoQuant shows that as of October 8, Bitcoin’s 30-day apparent demand has dropped to -13,707 BTC. This development marks the first negative reading since July, when the metric last turned red before rebounding strongly alongside Bitcoin’s summer rally.
Source: @ali_charts on X
Throughout August and September, Bitcoin’s apparent demand remained firmly positive, even as prices moved between $108,000 and $122,000, suggesting steady accumulation. However, the latest data shows a sharp reversal. The drop into negative territory could mean that long-term holders have started realizing profits or that buying momentum has temporarily slowed as traders assess the macro environment.
Interestingly, the macro environment has also become a growing concern for investors, as the United States and China appear poised for a renewed tariff standoff. Notably, US President Donald Trump has announced plans to impose a 100% tariff on all Chinese imports, following China’s proposal to introduce a sweeping export tax on several key goods.
Given the historical reaction of market price to tariff news seen during the early days of Trump’s administration, investor sentiment may remain subdued if this trade showdown persists, with many likely adopting a cautious stance until a clearer policy direction emerges.
Bitcoin Price Overview
At the time of writing, Bitcoin trades at $111,800, reflecting a 0.47% decline over the past 24 hours. On a monthly basis, the asset is down 3.06%, underscoring the intensity of the current corrective phase in the market.
Related Reading: Dogecoin Price Taps IMB Zone – What This Means And Where The Price Is Headed
BTC trading at $111,709 on the daily chart | Source: BTCUSDT chart on Tradingview.com
Featured image from iStock, chart from Tradingview
2025-10-12 11:135mo ago
2025-10-12 05:165mo ago
AI Will Kill Gold, But Bitcoin Emerges Stronger, Predicts Nick Szabo
In a provocative statement that has stirred conversations across both the crypto and traditional finance communities, Nick Szabo, the pioneering computer scientist and cryptographer, recently predicted that artificial intelligence (AI) could undermine gold's historical status as a store of value, while simultaneously strengthening Bitcoin's position in the financial ecosystem. Szabo, widely known for conceptualizing “smart contracts” and exploring digital scarcity, believes that technological advancements will fundamentally alter how we perceive traditional and digital assets.
Key NotesBNB price fell 9.6% but held above $1.000, on Saturday, outperforming rival large-cap cryptocurrencies.Data shows traders favored BNB and BTC in “flight-to-safety” trades amid $19 billion in liquidations.The exchange token sector proved more resilient, declining only 5.4% versus the 9% global crypto market drop.
BNB price held above $1,130 on Saturday, October 11, declining 9.6% in line with the broader market crash that wiped out $19 billion from the global crypto liquidation in 24 hours. Yet, key market data shows BNB displayed stronger resilience and remains better positioned for an early rebound than rival layer-1 tokens.
BNB and BTC Cut Losses to Single Digits Amid Flight-to-Safety Bets
BNB retraced from all-time highs of $1,330 on Monday to a weekly low of $1,043 during Friday’s crash before rebounding to $1,132 at press time. Notably, BNB’s 9.6% intraday loss outpaces its modest 7-day decline of only 1.7%, signalling strong buying pressure re-emerging at key psychological levels as weak hands exited.
Top 6 Cryptocurrencies performance on October 11, 2025 | Source: CoinMarketCap
Beyond that, Coinmarketcap data shows BNB’s limited drawdown places it alongside Bitcoin (-7.69%) as one of the only top-five cryptocurrencies keeping daily losses in single digits, despite market liquidations exceeding $19 billion in the past 24 hours. This highlights active “flight-to-safety” rotation toward BTC and BNB during the ongoing market dip.
Why Is BNB Price Holding Above $1,000?
BNB’s successful defence of the $1,000 during the crypto crash on October 11 can be attributed to improved sentiment after setting new all-time highs in three consecutive weeks, and incidental demand from the market turbulence.
As the native token of Binance, the world’s largest crypto exchange and second-largest DeFi ecosystem, BNB benefits from multiple demand catalysts, from trading fee discounts to increasing network revenue during heightened volatility.
Exchange Token Sector dips 5.4% as Global Crypto Market Cap plunges 9% on October 11, 2025 | Source: Coingecko
This dual function makes BNB an attractive hedge during market stress. Coingecko’s aggregate data on the crypto exchange tokens sector further reflects this narrative on Saturday. As seen above, the exchange token sector declined by only 5.4% to $221.4 billion in aggregate market capitalization on Saturday, outperforming the broader crypto market’s 9% contraction to $3.8 trillion.
Disclaimer: Coinspeaker is committed to providing unbiased and transparent reporting. This article aims to deliver accurate and timely information but should not be taken as financial or investment advice. Since market conditions can change rapidly, we encourage you to verify information on your own and consult with a professional before making any decisions based on this content.
Altcoin News, Cryptocurrency News, News
Ibrahim Ajibade is a seasoned research analyst with a background in supporting various Web3 startups and financial organizations. He earned his undergraduate degree in Economics and is currently studying for a Master’s in Blockchain and Distributed Ledger Technologies at the University of Malta.